Ascletis Pharma Inc.
ASCLF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,580,340 | $865,730 | $342,994 | $330,117 |
| Short-Term Investments | $199,898 | $1,081,801 | $1,736,698 | $1,969,286 |
| Receivables | $408 | $5,142 | $12,934 | $5,432 |
| Inventory | $4,822 | $4,373 | $6,484 | $6,071 |
| Other Curr. Assets | $16,771 | $13,736 | $16,276 | $21,850 |
| Total Curr. Assets | $1,822,936 | $1,970,782 | $2,115,386 | $2,332,756 |
| Property Plant & Equip (Net) | $51,990 | $57,204 | $65,237 | $68,538 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $10,915 | $12,118 | $24,417 | $26,315 |
| Long-Term Investments | $110,645 | -$997,410 | $70,755 | $63,024 |
| Tax Assets | $0 | $0 | $0 | -$261 |
| Other NC Assets | $349 | $1,081,878 | $269 | $637 |
| Total NC Assets | $173,899 | $153,790 | $160,678 | $158,253 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,996,835 | $2,124,572 | $2,276,064 | $2,491,009 |
| Liabilities | – | – | – | – |
| Payables | $20 | $31 | $464 | $649 |
| Short-Term Debt | $3,570 | $6,246 | $4,586 | $5,710 |
| Tax Payable | $0 | $4,078 | $0 | $1,722 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $121,535 | $142,698 | $81,711 | $132,598 |
| Total Curr. Liab. | $125,125 | $153,053 | $86,761 | $140,679 |
| LT Debt | $697 | $1,387 | $4,267 | $2,706 |
| Deferred Rev, NC | $0 | $3,970 | $0 | $5,558 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | -$5,558 |
| Other NC Liab. | $3,176 | $0 | $4,764 | $5,558 |
| Total NC Liab. | $3,873 | $5,357 | $9,031 | $8,264 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4,267 | $7,633 | $8,853 | $8,416 |
| Total Liabilities | $128,998 | $158,410 | $95,792 | $148,943 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $1,174,403 |
| Common Stock | $658 | $689 | $689 | $731 |
| Retained Earnings | $0 | -$1,475,339 | $0 | -$1,174,403 |
| AOCI | $1,867,179 | $747,551 | $2,179,583 | $0 |
| Other Equity | $0 | $2,693,261 | $0 | $2,791,182 |
| Total Equity | $1,867,837 | $1,966,162 | $2,180,272 | $2,342,066 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,996,835 | $2,124,572 | $2,276,064 | $2,491,009 |
| Net Debt | -$1,576,073 | -$858,097 | -$334,141 | -$321,701 |